Senseonics Holdings (SENS) Cash & Equivalents Growth (3y) (2017 - 2026)
Senseonics Holdings (SENS) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 40.99% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -0.70% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.52% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 28.25% |
| 10 | Senseonics Holdings | 329.46 Mn | 265.14 Mn | 6.94 Mn | -39.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.93% |
| Dec 31, 2025 | 228.50% |
| Sep 30, 2025 | -12.02% |
| Jun 30, 2025 | -40.62% |
| Mar 31, 2025 | -38.24% |
| Dec 31, 2024 | 159.60% |
| Sep 30, 2024 | 214.58% |
| Jun 30, 2024 | -45.47% |
| Mar 31, 2024 | 125.50% |
| Dec 31, 2023 | 61.41% |
| Sep 30, 2023 | 68.54% |
| Jun 30, 2023 | 10.10% |
| Mar 31, 2023 | 123.06% |
| Dec 31, 2022 | -77.21% |
| Sep 30, 2022 | 7.67% |
| Jun 30, 2022 | 32.09% |
| Mar 31, 2022 | 17.20% |
| Dec 31, 2021 | -68.53% |
| Sep 30, 2021 | -75.21% |
| Jun 30, 2021 | 5.34% |